Study S001701

Differences in Endothelial Function Amongst Sitagliptin and Liraglutide Users: A Randomized, Open-label, Parallel-group and Active Controlled Trial

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT01785043
Acronym: LAED001
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE4
Masking: NONE
Status: COMPLETED
Enrollment: 13
Start: 2013-03
Primary completion: 2014-03
Lead sponsor: Anna Cruceta
Conditions: DIABETES Mellitus Type 2 Not Well Controlled
Interventions: DRUG:Liraglutide; DRUG:Sitagliptin
Results posted: FALSE

Registered primary outcomes

Assess the effects on endothelial function of a three month treatment with Liraglutide compared to Sitagliptin. [3months]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.